Coya Therapeutics logo

Coya Therapeutics

COYA | NASDAQ
Chart Builder DCF Calculator
$3.00
-$0.13 (-4.15%)
At close: Nov 16, 2026, 4:00 PM ET
$2.96
-$0.04 (-1.33%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.15%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
31.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #748/1021 (Top 73%)

Key Statistics

Market Data

Market Cap $70.37M
1D Range
2.96 3.18
52W Range
2.81 6.51

Valuation (TTM)

PE -2.16
PB 2.10
EV/EBITDA -1.13

Valuation (NTM)

Forward PE N/A
Forward PEG -0.09
Price Target $12.00
Loading financial charts...

Profile

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipelin...

Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Dec 29, 2022
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.45
Miss -32.35%
REV
$234.13K
Beat +112.85%
Next Earnings
Mar 15, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$12.00
Upside
+300.00%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.